Six months continuation treatment in naltrexone-responsive children with autism: An open-label case-control design

Journal of Autism and Developmental Disorders

Volumn 29, Issue 2, 1999, Pages 167-169

  Willemsen Swinkels, Sophie H N ^a,c   Buitelaar, Jan K ^a   Van Berckelaer Onnes, Ina A ^b   Van Engeland, Herman ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b LEIDEN UNIVERSITY   (Netherlands)

^c UTRECHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

NALTREXONE;

ARTICLE; AUTISM; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEHYDRATION; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; HYPERACTIVITY; IRRITABILITY; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PSYCHOSOCIAL WITHDRAWAL; SCORING SYSTEM; SPEECH DISORDER; STEREOTYPY; TREATMENT OUTCOME; ATTENTION DEFICIT DISORDER; CHILD; HUMAN RELATION; PRESCHOOL CHILD; SOCIAL ADAPTATION;

ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; AUTISTIC DISORDER; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INTERPERSONAL RELATIONS; MALE; NALTREXONE; SOCIAL ADJUSTMENT;

EID: 0033110369     PISSN: 01623257     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1023000929040     Document Type: Article

References (19)

1. Aman, M. G., Singh, N. N., Stewart, A. W., & Field, C. J. (1985a). The Aberrant Behavior Checklist: A behavior rating scale for the assessment of treatment effects. American Journal of Mental Deficiency, 89, 485-491.
2. Aman, M. G., Singh, N. N., Stewart, A. W., & Field, C. J. (1985b). Psychometric characteristics of the Aberrant Behavior Checklist. American Journal of Mental Deficiency, 89, 492-502.
3. Buitelaar, J. K., Van Engeland, H., De Kogel, C. H., De Vries, H., Van Hooff, J. A. R. A. M., & Van Ree, J. M. (1992). The adrenocorticotrophic hormone (4-9) analog ORG-2766 benefits autistic children - Report on a second controlled clinical trial. Journal of the American Academy of Child and Adolescent Psychiatry, 31, 1149-1156.
4. Campbell, M., Anderson, L. T., Small, A. M., Adams, P., Gonzalez, N. M., & Ernst, M. (1993). Naltrexone in autistic children: Behavioral symptoms and attentional learning. Journal of the American Academy of Child and Adolescent Psychiatry, 32, 1283-1291.
5. Campbell, M., & Harris, J. C. (1996). Resolved: Autistic children should have a trial of naltrexone. Journal of the American Academy of Child and Adolescent Psychiatry, 35, 246-251.
6. Cooper, S. J. (1988). Evidence for opioid involvement in controls of drinking and water balance. In R. J. Rodgers & S. J. Cooper (Eds.), Endorphins, opiates and behavioural Processes. Chichester, U.K.: Wiley.
7. Fankhauser, M. P., Karumanchi, V. C., German, M. L., Yates, A., & Karumanchi, S. D. (1992). A double-blind, placebo-controlled study of the efficacy of transdermal clonidine in autism. Journal of Clinical Psychiatry, 53, 77-82.
8. Jaselskis, C. A., Cook, E. H. J., Fletcher, K. E., & Leventhal, B. L. (1992). Clonidine treatment of hyperactive and impulsive children. Journal of Clinical Psychopharmacology, 12, 322-327.
9. Kolmen, B. K., Feldman, H. M., Handen, B. L., & Janosky, J. E. (1995). Naltrexone in young autistic children: A double-blind, placebo-controlled crossover study. Journal of the American Academy of Child and Adolescent Psychiatry, 34, 223-231.
10. Kolmen, B. K., Feldman, H. M., Handen, B. L., & Janosky, J. E. (1997). Naltrexone in young autistic children: replication study and learning measures. Journal of the American Academy of Child and Adolescent Psychiatry, 36, 1570-1578.
11. Marshburn, E. C., & Aman, M. G. (1992). Factor validity and norms for the Aberrant Behavior Checklist in a community sample of children with mental retardation. Journal of Autism and Developmental Disorders, 22, 357-373.
12. Panksepp, J. (1979). A neurochemical theory of autism. Trends in Neurosciences, 2, 174-177.
13. Quintana, H., Birmaher, B., Stedge, D., Lennon, S., Freed, J., Bridge, J., & Greenhill, L. (1995). Use of methylphenidate in the treatment of children with autistic disorder. Journal of Autism and Developmental Disorders, 25, 283-294.
14. Schopler, E., & Reichler, R. J. (1979). Individualized assessment and treatment for autistic and developmentally disabled children: Vol. 1. Psychoeducational Profile. Baltimore: University Park Press.
15. Schopler, E., Reichler, R. J., & Renner, B. R. (1986). The Childhood Autism Rating Scale (CARS) for diagnostic screening and classification of autism. New York: Irvington.
16. Van Berckelaer-Onnes, I., & Van Duijn, G. (1993). A comparison between the Handicaps Behaviour and Skills Schedule and the Psychoeducational Profile. Journal of Autism and Developmental Disorders, 23, 263-272.
17. Willemsen-Swinkels, S. H. N., Buitelaar, J. K., Nijhof, G. J., & Van Engeland, H. (1995). Failure of naltrexone hydrochloride to reduce self-injurious and autistic behavior in mentally retarded adults. Archives of General Psychiatry, 52, 766-773.
18. Willemsen-Swinkels, S. H. N., Buitelaar, J. K., & Van Engeland, H. (1996). The effects of chronic naltrexone treatment in young autistic children: a double-blind placebo-controlled crossover study. Biological Psychiatry, 39, 1023-1031.
19. Willemsen-Swinkels, S. H. N., Buitelaar, J. K., Weijnen, F. G., & Van Engeland, H. (1995). Placebo-controlled acute dosage naltrexone study in young autistic children. Psychiatry Research, 58, 203-215.